Wearable single-lead ECG devices present opportunities and challenges for improving cardiac arrhythmia screening in low-resource settings like Ethiopia.
Cardiac arrhythmia, especially atrial fibrillation (AF) is a major cause of cardiovascular morbidity and mortality globally, particularly by raising the risk of heart failure and stroke. In low and middle-income countries (LMICs) such as Ethiopia, the AF burden is still poorly characterized, in part because of the insufficient diagnostic infrastructure and a poor population level surveillance and thus preventing the correct estimation of the real prevalence and impact of the disease (1).
Alemayehu et al. (Thu,) studied this question.